Login
  • Home
  • Direct Healthcare Professional Communications

all ( 17 results found)

Sort by:

Date Last Updated:

Medicine Status DHPC Document Name Additional Communications Company Kymriah 1.2 x 106 – 6 x 108 cells dispersion for infusion
No Recent Update

DHPC - Risk of secondary malignancy of T-cell origin in CD19- or BCMA-directed CAR T-cell therapies

COM 18/07/24
Novartis Ireland Limited Evrysdi 0.75 mg/mL powder for oral solution
Updated

Direct healthcare professional communication (DHPC) - Evrysdi 0.75 mg/mL powder for oral solution (risdiplam)

COM 21/08/25
Roche Registration GmbH Dzuveo 30 micrograms sublingual tablet
No Recent Update

Dzuveo cover letter

Dzuveo DHCP letter

COM 14/07/23 COM 14/07/23
Aguettant Ltd Epipen Junior 150 micrograms solution for injection in pre-filled pen
No Recent Update

EpiPen® Healthcare Professional Letter

COM 15/08/23
Mylan IRE Healthcare Ltd Epipen 300 micrograms solution for injection in pre-filled pen
No Recent Update

EpiPen® Healthcare Professional Letter

COM 15/08/23
Mylan IRE Healthcare Ltd Quinsair 240 mg nebuliser solution
No Recent Update

Fluoroquinolones DHPC_HPRA_FINAL vs2 30-05-23

COM 14/06/23
Chiesi Limited Adcortyl Intra-articular / Intradermal Injection 10mg/ml Suspension for Injection, 5ml
Discontinued

IE Adcortyl Discontinuation Letter June 2025

COM 04/07/25
Bristol-Myers Squibb Pharmaceuticals uc Infanrix Hexa, Powder and suspension for suspension for injection
No Recent Update

Infanrix Hexa - DHPC

COM 10/10/24
GlaxoSmithKline (Ireland) Ltd RISPERDAL 1 mg/ml oral solution
No Recent Update

Risperidone 1mg per ml OS-Risk of medication errors leading to accidental overdoses in children and adolescents

COM 28/02/25
Janssen Sciences Ireland (a Johnson & Johnson Company) Topamax Sprinkle 25 mg hard capsules
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

COM 02/11/23
Janssen Sciences Ireland (a Johnson & Johnson Company) Topamax Sprinkle 15 mg hard capsules
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

COM 02/11/23
Janssen Sciences Ireland (a Johnson & Johnson Company) Topamax 50mg film-coated tablets
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

COM 02/11/23
Janssen Sciences Ireland (a Johnson & Johnson Company) Topamax 25mg film-coated tablets
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

COM 02/11/23
Janssen Sciences Ireland (a Johnson & Johnson Company) Topamax 200mg film-coated tablets
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

COM 02/11/23
Janssen Sciences Ireland (a Johnson & Johnson Company) Topamax 100mg film-coated tablets
No Recent Update

Topiramate: New restrictions to prevent exposure during pregnancy

COM 02/11/23
Janssen Sciences Ireland (a Johnson & Johnson Company) Veoza 45 mg film-coated tablets
No Recent Update

Veoza - 45mg film-coated tablets_DHPC January 2025

COM 14/01/25
Astellas Pharma Co. Ltd Zolgensma 2 × 1013 vector genomes/mL solution for infusion
No Recent Update

Zolgensma (onasemnogene abeparvovec): Important Safety Information

COM 20/02/23
Novartis Ireland Limited